MSK Doctors (03300010048), a London-based private practice that specialises in treatments for musculoskeletal disorders, has released a new guide on arthrosamid hydrogel injections, which are designed to help individuals with knee arthritis.

Sleaford, United Kingdom, January 6, 2025 -- MSK Doctors's latest article explores arthrosamid injections as a novel, non-invasive long-term treatment for knee arthritis. With many clinical studies showing positive patient outcomes, MSK Doctors says that the option is suitable for individuals who are looking for an alternative to total knee replacement surgery.

For more information, please visit https://mskdoctors.com/treatments/arthrosamid

Of the estimated 10 million UK citizens who suffer from osteoarthritis, approximately 5.4 million people - one in five adults over 45 years of age - have knee osteoarthritis, according to numbers from Versus Arthritis. One study in the Osteoarthritis and Cartilage journal also suggests that knee osteoarthritis is one of the most common long-term conditions in the population, prompting many individuals to seek knee replacement surgery to improve their quality of life.

However, medical professionals have also begun to research effective, minimally invasive alternatives to surgery. Of the many methods studied, MSK Doctors’ guide highlights arthrosamid injection as a safe and viable option for relieving knee osteoarthritis pain.

As MSK Doctors explains, arthrosamid, also known as polyacrylamide (PAAG) hydrogel, is a non-degradable and non-resorbable hydrogel composed of cross-linked polyacrylamide and non-pyrogenic water. The hydrogel is injected into the knee joint, where it adheres to the synovial membrane and provides mechanical support to the knee, which MSK Doctors’ guide says can also help regenerate damaged tissue. This makes it more effective than hyaluronic acid for treating pain, stiffness, and physical function over a longer period of time.

Additionally, several case studies, including a 52-week prospective study and a six-month prospective study, have shown that patients experienced significant improvements in knee osteoarthritis symptoms and a reduction in bone marrow lesions following an arthrosamid injection. Professor Paul Lee, a consultant orthopaedic surgeon and the founder of MSK Doctors, has also conducted literature reviews of the procedure’s efficacy, noting that hydrogel injections typically provide positive results to patients for at least two years.

Arthrosamid injections are offered at MSK Doctors’ private clinics, which are situated throughout London. Individuals living with knee osteoarthritis who would prefer this treatment over traditional knee surgery are encouraged to contact the practice to book an appointment with one of its consultant orthopaedic surgeons to determine whether the procedure is right for them.

More information is available at https://mskdoctors.com/

Contact Info:
Name: Bethan Lee
Email: Send Email
Organization: MSK Doctors
Address: MSK House London Road Silk Willoughby, Sleaford, Lincolnshire, Sleaford, England NG34 8NY, United Kingdom
Website: https://www.mskdoctors.com

Source: PressCable

Release ID: 89150062

If there are any deficiencies, problems, or concerns regarding the information presented in this press release that require attention or if you need assistance with a press release takedown, we encourage you to notify us without delay at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team is committed to promptly addressing your concerns within 8 hours and taking necessary actions to rectify any identified issues or facilitate the removal process. Providing accurate and trustworthy information is of utmost importance.